Chiou Piao-Yi, Vincent Ben, Chen Ling-Xi, Li Chia-Lin, Chou Szu-Jui, Tsao Wei-Wen, Yu Jheng-Min, Hsu Sen-Chieh
School of Nursing, College of Medicine, National Taiwan University, Taipei City, Taiwan (R.O.C).
Department of Nursing, National Taiwan University Hospital, Taipei City, Taiwan (R.O.C).
Int J Transgend Health. 2024 Feb 13;26(3):765-778. doi: 10.1080/26895269.2024.2314147. eCollection 2025.
Trans women are a key global population affected by HIV infection. Although strategies have targeted to encourage trans women to complete HIV screening, frequency of testing in this population remains low.
To reveal barriers and facilitators for a tailored HIV testing model targeting trans women.
A convergent mixed-method was applied. Quantitative data were collected convenience sampling through online questionnaires, and qualitative data were collected quota sampling through semi-structured interviews.
In total, 213 participants were recruited with a mean age of 28.7 (SD = 7.57). A high percentage (67.1%, 143/213) of participants had never undergone HIV testing. They were more likely to have no monthly income, have been diagnosed or be experiencing gender dysphoria, have had condomless sex, and have current sexual partners with vaginal genital structure; many had never heard of HIV preventive medications. Integrated results showed that the barriers to accessing HIV testing included underestimated HIV risk, inadequate capacity of testing and results, insufficient access to preventive information within transgender community, and lack of dedicated screening resources. Facilitators included: delivering trustworthy messages through valuable channels and motivating companions through significant others, promoting the screener's competency of transgender culture; the screener's service experience should be available, and HIV testing options should be available gender affirmation therapy.
The mixed-method analysis promotes the clarification of previously unknown experiences that impede and facilitate trans women's access to HIV testing. This result could be applied to optimize the current HIV testing model to target trans women.
跨性别女性是受艾滋病毒感染影响的关键全球人群。尽管已制定策略鼓励跨性别女性完成艾滋病毒筛查,但该人群的检测频率仍然很低。
揭示针对跨性别女性的定制艾滋病毒检测模式的障碍和促进因素。
采用了收敛性混合方法。通过在线问卷以便利抽样的方式收集定量数据,通过半结构化访谈以配额抽样的方式收集定性数据。
总共招募了213名参与者,平均年龄为28.7岁(标准差=7.57)。高比例(67.1%,143/213)的参与者从未接受过艾滋病毒检测。他们更有可能没有月收入,被诊断患有或正在经历性别焦虑症,有无保护措施的性行为,以及当前的性伴侣具有阴道生殖器结构;许多人从未听说过艾滋病毒预防药物。综合结果表明,获得艾滋病毒检测的障碍包括对艾滋病毒风险的低估、检测和结果的能力不足、跨性别群体内部预防信息获取不足以及缺乏专门的筛查资源。促进因素包括:通过有价值的渠道传递可信信息,通过重要他人激励同伴,提高筛查人员对跨性别文化的能力;筛查人员应具备服务经验,并且艾滋病毒检测选项应与性别肯定治疗同时提供。
混合方法分析有助于澄清以前未知的阻碍和促进跨性别女性获得艾滋病毒检测的经历。这一结果可用于优化当前针对跨性别女性的艾滋病毒检测模式。